This excerpt taken from the EYE 8-K filed Jan 10, 2007.
Revised Financial Guidance
AMO expects the transaction to be dilutive to 2007 adjusted earnings per share (EPS) and slightly accretive to 2008 adjusted EPS. As a result of this transaction, AMO expects amortization to increase by approximately $30 million on an annualized basis, which would bring the companys total annual amortization to approximately $70 million or about $0.70 per share on an after-tax basis. For more information, see the Use of Non-GAAP Measures section later in this release. Assuming successful close of the transaction early in the second quarter of 2007, AMOs financial guidance is as follows:
UBS Investment Bank is acting as lead financial advisor and Goldman Sachs is acting as co-financial advisor to AMO. UBS Investment Bank is acting as lead arranger of a $900 million acquisition facility for AMO. Bank of America and Goldman Sachs are acting as joint-arrangers of the acquisition facility. Bank of America is acting as lead financial advisor and JPMorgan is acting as co-financial advisor to IntraLase. Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal advisor to AMO. Stradling Yocca Carlson & Rauth is acting as legal advisor to IntraLase.